Global Dry Powder Inhaler Device Supply, Demand and Key Producers, 2026-2032

The global Dry Powder Inhaler Device market size is expected to reach $ 1284 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032).

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report studies the global Dry Powder Inhaler Device production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dry Powder Inhaler Device and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dry Powder Inhaler Device that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Dry Powder Inhaler Device total production and demand, 2021-2032, (K Units)

Global Dry Powder Inhaler Device total production value, 2021-2032, (USD Million)

Global Dry Powder Inhaler Device production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)

Global Dry Powder Inhaler Device consumption by region & country, CAGR, 2021-2032 & (K Units)

U.S. VS China: Dry Powder Inhaler Device domestic production, consumption, key domestic manufacturers and share

Global Dry Powder Inhaler Device production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)

Global Dry Powder Inhaler Device production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

Global Dry Powder Inhaler Device production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

This report profiles key players in the global Dry Powder Inhaler Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dry Powder Inhaler Device market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Dry Powder Inhaler Device Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Dry Powder Inhaler Device Market, Segmentation by Type:
Single Dose
Multi Dose

Global Dry Powder Inhaler Device Market, Segmentation by Application:
Asthma
COPD
Others

Companies Profiled:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura

Key Questions Answered:

1. How big is the global Dry Powder Inhaler Device market?

2. What is the demand of the global Dry Powder Inhaler Device market?

3. What is the year over year growth of the global Dry Powder Inhaler Device market?

4. What is the production and production value of the global Dry Powder Inhaler Device market?

5. Who are the key producers in the global Dry Powder Inhaler Device market?

6. What are the growth factors driving the market demand? Show more